Anti-inflammatory agent 17 is a potent, orally active anti-inflammatory drug; it inhibits the release of IL-6 and TNF-α in vitro without cytotoxicity, exhibits anti-inflammatory activity in vivo, and has potential for the study of acute lung injury (ALI).